Express News | NextCure Announces Acceptance of Ind Application for Lncb74

BreakingsDec 10 21:05

NextCure Announces Acceptance of IND Application for LNCB74

GlobeNewswireDec 10 21:05

Piper Sandler Maintains NextCure(NXTC.US) With Buy Rating, Maintains Target Price $3

Futu NewsDec 6 20:31 · Ratings

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

GlobeNewswireNov 26 20:00

NextCure Highlights Presentation Of Data Demonstrating That NC605 Resulted In Enhanced Generation Of Quality Bone With Better Mechanical Properties

BenzingaNov 19 21:11

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone With Better Mechanical Properties in Mice With Moderate-to-Severe Osteogenesis Imperfecta

GlobeNewswireNov 19 21:05